175 related articles for article (PubMed ID: 35666743)
1. Down-expression of klotho in canine mammary gland tumors and its prognostic significance.
Chung H; Lee S; Kim GA; Kim WH
PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.
Carvalho MI; Pires I; Prada J; Lobo L; Queiroga FL
Vet Pathol; 2016 Nov; 53(6):1138-1146. PubMed ID: 27162119
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of SLUG expression in canine mammary gland tumors and its prognostic significance.
Cheon SB; Kim WH
BMC Vet Res; 2023 Aug; 19(1):112. PubMed ID: 37553661
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours.
Rodrigues H; Carvalho MI; Pires I; Prada J; Queiroga FL
Acta Vet Hung; 2016 Mar; 64(1):78-89. PubMed ID: 26919145
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.
Zuccari DA; Santana AE; Cury PM; Cordeiro JA
Vet Clin Pathol; 2004; 33(1):23-8. PubMed ID: 15048623
[TBL] [Abstract][Full Text] [Related]
6. Reduced Klotho expression and its prognostic significance in canine hepatocellular carcinoma.
Kim G; Chung H; Lee S; Kim WH
Vet Comp Oncol; 2023 Mar; 21(1):91-99. PubMed ID: 36482288
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.
Santos AA; Lopes CC; Marques RM; Amorim IF; Gärtner MF; de Matos AJ
Am J Vet Res; 2012 May; 73(5):689-97. PubMed ID: 22533401
[TBL] [Abstract][Full Text] [Related]
8. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
[TBL] [Abstract][Full Text] [Related]
11. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of ATM Gene and Protein Expression in Canine Mammary Tumors.
Raposo-Ferreira TM; Bueno RC; Terra EM; Avante ML; Tinucci-Costa M; Carvalho M; Cassali GD; Linde SD; Rogatto SR; Laufer-Amorim R
Vet Pathol; 2016 Nov; 53(6):1154-1159. PubMed ID: 27106737
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
15. CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors.
Rogez B; Pascal Q; Bobillier A; Machuron F; Lagadec C; Tierny D; Le Bourhis X; Chopin V
Vet Pathol; 2019 May; 56(3):377-388. PubMed ID: 30558511
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic value of TRPM7 in canine mammary tumours.
Lee S; Lee S; Kim WH
Vet Comp Oncol; 2021 Sep; 19(3):510-517. PubMed ID: 33617107
[TBL] [Abstract][Full Text] [Related]
17. The expression of sialyl Lewis X in canine and feline mammary gland tumors.
Nakagawa T; Uyama R; Ohashi E; Takahashi T; Hong SH; Mochizuki M; Matsunaga S; Nishimura R; Sasaki N
J Vet Med Sci; 2002 Oct; 64(10):949-52. PubMed ID: 12419875
[TBL] [Abstract][Full Text] [Related]
18. Haemoglobin in normal and neoplastic canine mammary glands.
Chang SC; Chen HF; Chou MH; Wang HC; Su HY; Wong ML
Vet Comp Oncol; 2010 Dec; 8(4):302-9. PubMed ID: 21062412
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
[TBL] [Abstract][Full Text] [Related]
20. Alpha basic crystallin expression in canine mammary tumors.
Guvenc T; Gulbahar MY; Yarim M; Kabak YB; Karayigit O; Sozmen M
J Vet Sci; 2012 Mar; 13(1):39-42. PubMed ID: 22437534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
